| abstract |
A compound having the formula (I), ** Formula ** or a pharmaceutically acceptable salt, solvate, stereoisomer and / or hydrate thereof, wherein: Q is a phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl ring, and R9, R10, and R11 are each independently selected from hydrogen, C1-4 alkyl O (C1-4 alkyl), halogen, C1-4 haloalkyl, cyano, SO2 (C1-4 alkyl) and / or nitro; R6 is C1-6 alkyl or cyclopropyl; R2 is selected from C1-4 alkyl, NR7R8 and C1-4 alkyl substituted with a group NR7R8; and R7 and R8 are independently selected from hydrogen, C1-6 alkyl, and C3-6 cycloalkyl, each of said R7 and R8 groups, in turn, optionally substituted with one to two OH, O (C1-6 alkyl -4), imidazolyl, pyridyl, phenyl, tetrahydrofuryl, NH2, NH (C1-4 alkyl), N (C1-4 alkyl), and N-morpholinyl, or, alternatively, R7 and R8 are taken together with the atom of nitrogen to which they are attached to form a morpholinyl, piperidinyl or piperazinyl ring. |